Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has actually axed its own once-monthly double GLP-1/ GIP receptor agonist, finishing (...

Daiichi pays for Merck $170M to create lung cancer T-cell engager pact

.Merck &amp Co. has quickly recouped some of the costs of its own Javelin Therapeutics buyout, attra...

BioMarin standstills preclinical genetics treatment for heart disease

.After BioMarin performed a springtime well-maintained of its pipe in April, the firm has decided th...

Eisai plants molecular adhesive SEED along with $1.5 B biobucks handle

.Large Pharmas remain stuck to the concept of molecular glue degraders. The most up to date business...

Life scientific research credit rating company unveils along with $600M

.A brand-new global lifestyle science credit score organization, referred to Symbiotic Funds, has ac...

BMS channels TIGIT, ignoring $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing yet another large wager from the Caforio age, terminating a ...

Nuvation standstills wager inhibitor after considering stage 1 record

.After taking a look at phase 1 data, Nuvation Biography has actually chosen to halt deal with its s...

' Professional intuition' led FDA experts to support Zevra's unusual disease med

.Zevra Therapies' rare illness drug appears to be on the course to authorization this autumn after a...

Pfizer takes $230M reached after axing fell short DMD genetics treatment

.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) genetics treatment failing has gone a $230 million...

AC Immune views 'spots' possible in Alzheimer's drug records

.After greater than 20 years of deal with neurodegenerative diseases, Swiss biotech air conditioning...